Patents by Inventor Uwe Pieles

Uwe Pieles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190247540
    Abstract: The present invention provides a composition comprising specific self-assembling peptides, which are capable of self-assembly at a pH below 7.5 and at least physiologic ionic strength, e.g., PI 1-4. PI 1-8, PI 1-14, PI 1-13, PI 1-12, PI 1-28, PI 1-29, PI 1-2, PI 1-5, PI 1-17, PI 1-19, PI 1-20, PI 1-12, PI 1-16, PI 1-18, PI 1-26 or PI 1-31 for use in treating an oral disease selected from the group consisting of gingivitis, periodontitis and/or peri-implantitis in a subject. Said composition may be used, after suitable cleaning procedures, for filling pockets formed adjacent to teeth in said diseases, which enhances tissue regeneration. The composition may be suitable for controlled release of an active agent, e.g., an antimicrobial or antibiotic agent. The invention also provides a kit suitable for said treatment further comprising self-assembling peptides suitable for forming a second layer on top of the first composition.
    Type: Application
    Filed: August 16, 2017
    Publication date: August 15, 2019
    Inventors: Michael Hug, Dominikus Amadeus Lysek, Franziska Koch, Ronald Jung, Stephanie Mathes, Nina Meyer, Christoph Hämmerle, Frank Bröseler, Uwe Pieles
  • Publication number: 20090293950
    Abstract: A photovoltaic cell, particularly a color-sensitized solar cell, comprises a conductive support substrate, coated with a metal oxide semiconductor layer, a color layer embodied so as to electronically interact with the metal oxide semiconductor layer, an electrolyte later that is applied to the color layer, and a counter-electrode which is connected to the electrolyte layer. The support substrate and/or the counter-electrode is/are made from a flexible fabric composed of a plurality of interwoven fibers.
    Type: Application
    Filed: May 14, 2007
    Publication date: December 3, 2009
    Applicants: SEFAR AG, THE UNIVERSITY OF BASEL, FACHHOCHSCHULE NORDWESTSCHWEIZ
    Inventors: Peter Chabrecek, Egbert Figgemeier, Uwe Pieles
  • Patent number: 6289144
    Abstract: The invention relates to a sensor platform based on at least two planar, separate, inorganic dielectric waveguiding regions on a common substrate and to a method for the parallel evanescent excitation and detection of the luminescence of identical or different analytes. The invention relates also to a modified sensor platform that consists of the sensor platform having the planar, separate, inorganic dielectric waveguiding regions and one or more organic phases immobilised thereon. A further subject of the invention is the use of the sensor platform or of the modified sensor platform in a luminescence detection method for quantitative affinity sensing and for the selective quantitative determination of luminescent constituents of optically opaque solutions.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: September 11, 2001
    Assignee: Novartis AG
    Inventors: Dieter Neuschäfer, Gert Ludwig Duveneck, Michael Pawlak, Uwe Pieles, Wolfgang Budach
  • Patent number: 6078705
    Abstract: The invention relates to a sensor platform based on at least two planar, separate, inorganic dielectric waveguiding regions on a common substrate and to a method for the parallel evanescent excitation and detection of the luminescence of identical or different analytes. The invention relates also to a modified sensor platform that consists of the sensor platform having the planar, separate, inorganic dielectric waveguiding regions and one or more organic phases immobilised thereon. A further subject of the invention is the use of the sensor platform or of the modified sensor platform in a luminescence detection method for quantitative affinity sensing and for the selective quantitative determination of luminescent constituents of optically opaque solutions.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: June 20, 2000
    Assignee: Novartis AG
    Inventors: Dieter Neuschafer, Gert Ludwig Duveneck, Michael Pawlak, Uwe Pieles, Wolfgang Budach
  • Patent number: 5925744
    Abstract: The present invention relates to cyclic terpyridine-lanthanide complexes having 8 nitrogen atoms and 10 carbon atoms in the macrocycle and containing a functional group in the terpyridine moiety. The invention also relates to a process for the preparation of cyclic terpyridine-lanthanide complexes through the condensation of terpyridine hydrazines with pyridine-2,6-dialdehydes or -ketones. The compounds can be complexed with oligonculeotides and are useful in the sequence-specific cleavage of RNA.
    Type: Grant
    Filed: July 28, 1997
    Date of Patent: July 20, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Robert Haner, Jonathan Hall, Dieter Husken, Uwe Pieles, Heinz Moser
  • Patent number: 5506348
    Abstract: The invention relates to a composition comprising(a) at least one ammonium salt of an inorganic or organic acid,(b) a compound of formula I ##STR1## wherein R is an aliphatic hydrocarbon radical of 1 to 12 carbon atoms or an aliphatic hydrocarbon radical of 2 to 12 carbon atoms which is interrupted by --O-- atoms, and n is an integer from 1 to 5, and(c) at least one high molecular weight compound selected from the group consisting of the polynucleotides, oligosaccharides, proteins and macrocyclic metal complexes, and to the use thereof for the matrix-assisted laser desorption mass spectroscopy of oligonucleotide sequences.
    Type: Grant
    Filed: February 24, 1994
    Date of Patent: April 9, 1996
    Assignee: Ciba-Geigy Corporation
    Inventor: Uwe Pieles
  • Patent number: 5112963
    Abstract: The present invention provides modified oligonucleotides, wherein, amongst the first four bases on the 5'-end, they have the base sequence AT or TA and, bound to one of the two O.sup.- groups of the 5'-phosphate group of the first nucleotide at the 5'-end of said oligonucleotide, they contain a radical of the general formula: ##STR1## in which R.sub.4 is a spacer group and R.sub.1, R.sub.2 and R.sub.3 are hydrogen atoms or alkyl or alkoxy radicals containing up to 3 carbon atoms.These modified oligonucleotides can be used for blocking the replication and/or expression of genes which have a sequence complementary with the modified oligonucleotides.
    Type: Grant
    Filed: November 14, 1988
    Date of Patent: May 12, 1992
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
    Inventors: Uwe Pieles, Uwe Englisch, Friedrich Cramer